GSK Investigational Site

Camp Hill, Pennsylvania 17011

0 studies enrolling now · 10 studies all time

What they study most

Acute Coronary Syndrome, Atherosclerosis, Atrial Fibrillation, Deep Vein Thrombosis, Diabetes Mellitus, Fibrillation, Atrial, Hypertension, Hypertrophy, Left Ventricular, Neoplasms, Prostate, Pulmonary Embolism, Venous Thromboembolism

Studies at this site

• Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus — Completed
• A Study to Evaluate the Safety of 12 Weeks of Dosing With GW856553 and Its Effects on Inflammatory Markers, Infarct Size, and Cardiac Function in Subjects With Myocardial Infarction Without ST-segment Elevation — Completed
• The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial — Completed
• Odiparcil For The Prevention Of Venous Thromboembolism — Completed
• Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes — Completed
• Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke — Completed
• The CLEVER Study - Coreg And Left Ventricular Mass Regression — Completed
• "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk — Completed
• SB-480848 In Subjects With Coronary Heart Disease — Completed
• Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension — Completed